Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Bioadaptives (BDPT) Beginning Cash Balance (2021 - 2023)

Bioadaptives' Beginning Cash Balance history spans 3 years, with the latest figure at $50000.0 for Q3 2023.

  • For Q3 2023, Beginning Cash Balance changed N/A year-over-year to $50000.0; the TTM value through Dec 2024 reached $50000.0, changed 0.0%, while the annual FY2023 figure was $50000.0, 2980.71% up from the prior year.
  • Beginning Cash Balance for Q3 2023 was $50000.0 at Bioadaptives, up from $1623.0 in the prior quarter.
  • Across five years, Beginning Cash Balance topped out at $50000.0 in Q3 2023 and bottomed at $1623.0 in Q1 2021.
  • The 3-year median for Beginning Cash Balance is $1623.0 (2021), against an average of $17748.7.
  • The largest YoY upside for Beginning Cash Balance was 0.0% in 2022 against a maximum downside of 0.0% in 2022.
  • A 3-year view of Beginning Cash Balance shows it stood at $1623.0 in 2021, then changed by 0.0% to $1623.0 in 2022, then soared by 2980.71% to $50000.0 in 2023.
  • Per Business Quant, the three most recent readings for BDPT's Beginning Cash Balance are $50000.0 (Q3 2023), $1623.0 (Q1 2022), and $1623.0 (Q1 2021).